Tobacco use, cancer causation and public health impact

Journal of Internal Medicine

Volumn 251, Issue 6, 2002, Pages 455-466

  Kuper, H ^a   Adami, H O ^b   Boffetta, P ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer; Carcinogenesis; Smoking; Tobacco

Indexed keywords

CARCINOGEN; CATECHOLAMINE; CORTICOTROPIN; DNA; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN; NICOTINE;

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; LOWEST INCOME GROUP; LUNG CARCINOGENESIS; LUNG CARCINOMA; PASSIVE SMOKING; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS;

ADULT; AGED; CARCINOGENS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PUBLIC HEALTH; SMOKING; TOBACCO, SMOKELESS; WORLD HEALTH;

EID: 0036091036     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00993.x     Document Type: Review

References (76)

1. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985
2. Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: Findings from the WHO MONICA Project
3. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies
4. Smoking and carcinoma of the lung. Preliminary report
5. The mortality of doctors in relation to their smoking habits. A preliminary report
6. Smokeless tobacco and cancer: An overview
7. Smokeless tobacco
8. Tobacco
9. Do smokers of lower tar cigarettes consume lower amounts of smoke components? ]Results from the Scottish Heart Health Study
10. Mortality in relation to tar yield of cigarettes: A prospective study of four cohorts
11. Nitrogen-containing compounds in tobacco and tobacco smoke
12. Cigarette smoking
13. Cigarette smoking and nicotine addiction
14. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
15. An international literature survey of 'IARC Group I carcinogens' reported in mainstream cigarette smoke
16. 'IARC Group 2B carcinogens' reported in cigarette mainstream smoke
17. Plasma cotinine: Stability in smokers and validation of self-reported smoke exposure in nonsmokers
18. Saliva cotinine levels in smokers and nonsmokers
19. Smoking characteristics and inhalation biochemistry in the Scottish population
20. Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells
21. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients
22. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths
23. Tobacco smoke carcinogens and lung cancer
24. Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa
25. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database
26. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer
27. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use
28. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
29. Genotoxicity testing of extracts of a Swedish moist oral snuff
30. The antiestrogenic effect of cigarette smoking in women
31. Predictors of sex hormone levels among the elderly: A study in Greece
32. Immunomodulatory effects of cigarette smoke
33. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers
34. Lung cancer and passive smoking
35. Passive smoking and lung cancer
36. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe
37. The accumulated evidence on lung cancer and environmental tobacco smoke
38. Risk of lung cancer and passive smoking
39. Occupational factors of lung cancer
40. Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden
41. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype
42. Contribution of genetic and nutritional factors to DNA damage in heavy smokers
43. The data support a role for antioxidants in reducing cancer risk
44. Mortality risks of oesophageal cancer associated with hot tea, alcohol, tobacco and diet in Japan
45. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women
46. Alcohol consumption, smoking and risk of gastric cancer: A case-control study from Moscow, Russia
47. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma
48. Penetration of N-nitrosonornicotine (NNN) across oral mucosa in the presence of ethanol and nicotine
49. Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise
50. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer
51. Synergy between asbestos and smoking on lung cancer risks
52. Gender- and smoking-related bladder cancer risk
53. Hormonal risk factors for endometrial cancer: Modification by cigarette smoking (United States)
54. Risk of urinary bladder cancer among blacks and whites: The role of cigarette use and occupation
55. Smoking and bladder cancer risk in blacks and whites in the United States
56. Nicotine metabolism and intake in black and white smokers
57. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers
58. The role of gene-environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung and breast
59. Pharmacogenetics of cytochromes P450
60. Genetic polymorphism of CYP2A6 in relation to cancer
61. CYP2A6 gene deletion reduces susceptibility to lung cancer
62. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
63. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction
64. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England
65. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population
66. A germline homozygote deletion of the glutathione-S-transferase Mu1 gene predisposes to bladder cancer
67. Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking
68. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes
69. Emerging tobacco hazards in China: 2. Early mortality results from a prospective study
70. Mortality in relation to smoking: 40 Years' observations on male British doctors